Clinical Trials Logo

Clinical Trial Summary

This study aimed to investigate the therapeutic effect of subcutaneous erythropoietin in the management of late stage optic neuropathy.


Clinical Trial Description

Injury of the optic nerve or optic neuropathy is one of the most common causes of vision loss. This study aimed to investigate the therapeutic effect of subcutaneous erythropoietin in the management of late stage optic neuropathy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04469777
Study type Interventional
Source Alexandria University
Contact
Status Completed
Phase Phase 1/Phase 2
Start date April 1, 2019
Completion date December 30, 2020

See also
  Status Clinical Trial Phase
Terminated NCT02982499 - Biomechanics of Optic Neuropathy
Recruiting NCT05543018 - Effect of Intraocular Tamponade on Visual Perception N/A
Completed NCT03318549 - BCI and Evaluation of Visual and Task Performance in Subjects With Eye Diseases N/A
Terminated NCT03536559 - Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis Phase 2
Recruiting NCT06128720 - Hyperbaric Oxygen Therapy for Optic Neuropathies N/A
Withdrawn NCT01331616 - Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab Early Phase 1
Not yet recruiting NCT05747781 - STReetlab Assessment Tool of Activities Daily Living in Glaucoma Patient N/A
Completed NCT01166594 - Use of Bevacizumab in Trabeculectomy Surgery Phase 4
Completed NCT03268681 - BIOtinidase Test In Optic-Neuropathy
Completed NCT02612571 - Comparing Rates of Glaucoma in Professional Wind Versus Non-Wind Instrument Players N/A
Recruiting NCT03011541 - Stem Cell Ophthalmology Treatment Study II N/A
Completed NCT05853003 - Neuromuscular Ultrasonography Assessment of Optic Nerve in Systemic Lupus Eryhematosus
Enrolling by invitation NCT03760055 - Assessment of Visual Function With a Portable Brain-computer Interface
Recruiting NCT02638714 - Treatment of Optic Neuropathies Using Autologous Bone Marrow-Derived Stem Cells Phase 1/Phase 2